SG11201805771XA - Systems and methods for preparation of platelets - Google Patents

Systems and methods for preparation of platelets

Info

Publication number
SG11201805771XA
SG11201805771XA SG11201805771XA SG11201805771XA SG11201805771XA SG 11201805771X A SG11201805771X A SG 11201805771XA SG 11201805771X A SG11201805771X A SG 11201805771XA SG 11201805771X A SG11201805771X A SG 11201805771XA SG 11201805771X A SG11201805771X A SG 11201805771XA
Authority
SG
Singapore
Prior art keywords
international
systems
methods
stanwell
concord
Prior art date
Application number
SG11201805771XA
Other languages
English (en)
Inventor
Elan Weiner
William Greenman
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Publication of SG11201805771XA publication Critical patent/SG11201805771XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0281—Apparatus for treatment of blood or blood constituents prior to transfusion, e.g. washing, filtering or thawing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • A61M1/382—Optimisation of blood component yield
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • A61M1/382—Optimisation of blood component yield
    • A61M1/385—Optimisation of blood component yield taking into account of the patient characteristics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • A61M1/382—Optimisation of blood component yield
    • A61M1/387—Optimisation of blood component yield taking into account of the needs or inventory
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11201805771XA 2016-01-07 2017-01-06 Systems and methods for preparation of platelets SG11201805771XA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662276223P 2016-01-07 2016-01-07
US201662311373P 2016-03-21 2016-03-21
PCT/US2017/012633 WO2017120545A2 (en) 2016-01-07 2017-01-06 Systems and methods for preparation of platelets

Publications (1)

Publication Number Publication Date
SG11201805771XA true SG11201805771XA (en) 2018-08-30

Family

ID=58010366

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201805771XA SG11201805771XA (en) 2016-01-07 2017-01-06 Systems and methods for preparation of platelets

Country Status (10)

Country Link
US (1) US20200078406A1 (ja)
EP (1) EP3399986B1 (ja)
JP (2) JP7324002B2 (ja)
CN (1) CN108697738A (ja)
BR (1) BR112018013932A2 (ja)
EA (1) EA201891577A1 (ja)
IL (1) IL260393B2 (ja)
MX (1) MX2018008359A (ja)
SG (1) SG11201805771XA (ja)
WO (1) WO2017120545A2 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11096963B2 (en) 2015-06-26 2021-08-24 Cerus Corporation Cryoprecipitate compositions and methods of preparation thereof
ES2972443T3 (es) 2015-10-23 2024-06-12 Cerus Corp Plasma pobre en crioprecipitado inactivado para patógenos y métodos de uso del mismo
EP3589297A1 (en) 2017-03-03 2020-01-08 Cerus Corporation Kits and methods for preparing pathogen-inactivated platelet compositions
WO2019060610A1 (en) * 2017-09-20 2019-03-28 Cerus Corporation COMPOSITIONS AND METHODS FOR INACTIVATION OF PLATELET PATHOGENS
WO2019133929A1 (en) 2017-12-29 2019-07-04 Cerus Corporation Systems and methods for treating biological fluids
US12011510B2 (en) 2019-06-22 2024-06-18 Cerus Corporation Biological fluid treatment systems
JP2022539154A (ja) 2019-06-28 2022-09-07 シーラス コーポレイション 生物学的流体処理デバイスを実装するためのシステム及び方法
US20220244093A1 (en) * 2021-01-29 2022-08-04 Fenwal, Inc. Automated Splitting Of A Fluid Into Uneven Volumes
WO2022173955A1 (en) * 2021-02-11 2022-08-18 Secure Transfusion Services, Inc. Machine learning model based platelet donor selection

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232844A (en) 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
CA2089005C (en) 1991-06-21 1999-01-19 John Chapman Method for inactivating pathogens in a body fluid
US5709991A (en) 1992-03-02 1998-01-20 Cerus Corporation Proralen inactivation of microorganisms and psoralen removal
WO1996008965A1 (en) 1994-09-22 1996-03-28 Baxter International, Inc. Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
JP4968974B2 (ja) 1995-06-07 2012-07-04 セラス コーポレーション 血液製剤からソラレンを除去するための方法およびデバイス
US20020192632A1 (en) * 1995-06-07 2002-12-19 Hei Derek J. Method and devices for the removal of psoralens from blood products
AU6267496A (en) 1995-06-07 1996-12-30 Steritech, Inc. Methods of inactivating leukocytes and inhibiting cytokine p roduction in blood products
US6544727B1 (en) * 1995-06-07 2003-04-08 Cerus Corporation Methods and devices for the removal of psoralens from blood products
US6190855B1 (en) 1996-10-28 2001-02-20 Baxter International Inc. Systems and methods for removing viral agents from blood
CA2276747C (en) * 1997-01-06 2004-04-13 Cerus Corporation Methods and devices for the reduction of small organic compounds from blood products
US7611831B2 (en) * 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
CN1284897A (zh) * 1998-01-06 2001-02-21 塞鲁斯公司 降低含细胞的生物组合物中化合物的批量设备和使用方法
US7025877B1 (en) 1999-06-03 2006-04-11 Baxter International Inc. Processing set for processing and treating a biological fluid
US7430478B2 (en) * 2000-03-01 2008-09-30 Caridian Bct, Inc. Blood processing information system with blood loss equivalency tracking
US6936413B1 (en) * 2001-12-05 2005-08-30 Baxter International Inc. Methods and systems for preparing blood products
US7264608B2 (en) 2001-12-05 2007-09-04 Fenwal, Inc. Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
JP2005519744A (ja) 2002-03-14 2005-07-07 バクスター・インターナショナル・インコーポレイテッド 化合物除去器
WO2003090794A1 (en) 2002-04-26 2003-11-06 Gambro, Inc. Solution containing platelet activation inhibitors for pathogen reducing and storing blood platelets
US8296071B2 (en) 2004-03-15 2012-10-23 Terumo Bct Biotechnologies, Llc Methods for uniformly treating biological samples with electromagnetic radiation
DE102005062410A1 (de) * 2005-12-23 2007-08-09 Forschungsgemeinschaft Der Drk-Blutspendedienste E.V. Verfahren zur Bestrahlung von Thrombozytenkonzentraten in flexiblen Behältnissen mit ultraviolettem Licht
US8075468B2 (en) * 2008-02-27 2011-12-13 Fenwal, Inc. Systems and methods for mid-processing calculation of blood composition
US8782543B2 (en) * 2008-02-27 2014-07-15 Fenwal, Inc. Product options calculator for a blood processing system
US8753807B2 (en) * 2009-06-02 2014-06-17 Biolitec Pharma Marketing Ltd Method for microbes depletion in human blood or full serum using antimicrobial photodynamic laser therapy
US8715920B2 (en) 2010-07-27 2014-05-06 Biovec Transfusion, Llc Composition for preserving platelets during photosensitization
US8877060B2 (en) 2010-11-23 2014-11-04 Biovec Transfusion, Llc Methods for removing pathogens from a platelet preparation
US20120010062A1 (en) * 2010-07-09 2012-01-12 Caridianbct, Inc. Blood processing apparatus and method with automatically adjusted collection targets
US20120109677A1 (en) * 2010-11-01 2012-05-03 New York Blood Center, Inc. Blood bank management and rapid blood type determination system
WO2012075041A2 (en) * 2010-11-29 2012-06-07 New York Blood Center, Inc. Method of blood pooling and storage
IL210162A0 (en) * 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
WO2014051537A1 (en) * 2012-09-25 2014-04-03 Biovec Transfusion, Llc Device and method for removing additives in the blood products
WO2014099513A1 (en) * 2012-12-19 2014-06-26 Advanced Preservations Technologies, Llc Device for preserving blood products in a gas medium under pressure
US10039877B2 (en) * 2013-08-23 2018-08-07 Fenwal, Inc. Apheresis platelets with fixed residual plasma volume
WO2016014854A1 (en) * 2014-07-23 2016-01-28 Cerus Corporation Methods for preparing platelet products
US11096963B2 (en) * 2015-06-26 2021-08-24 Cerus Corporation Cryoprecipitate compositions and methods of preparation thereof

Also Published As

Publication number Publication date
WO2017120545A2 (en) 2017-07-13
IL260393B2 (en) 2024-06-01
US20200078406A1 (en) 2020-03-12
MX2018008359A (es) 2019-01-31
WO2017120545A3 (en) 2017-08-24
JP2021119184A (ja) 2021-08-12
JP2019507726A (ja) 2019-03-22
CN108697738A (zh) 2018-10-23
EA201891577A1 (ru) 2019-02-28
IL260393A (ja) 2018-09-20
JP7324002B2 (ja) 2023-08-09
BR112018013932A2 (pt) 2018-12-11
EP3399986B1 (en) 2023-02-22
IL260393B1 (en) 2024-02-01
EP3399986A2 (en) 2018-11-14

Similar Documents

Publication Publication Date Title
SG11201805771XA (en) Systems and methods for preparation of platelets
SG11201811432WA (en) Rna for cancer therapy
SG11201809344QA (en) Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
SG11201811151PA (en) Extracellular vesicle comprising a fusion protein having fc binding capacity
SG11201805162VA (en) Plasmid constructs for heterologous protein expression and methods of use
SG11201900028VA (en) Crispr/cas9-based compositions and methods for treating cancer
SG11201805072PA (en) Nicotine powder delivery system
SG11201808990QA (en) Compositions for topical application of compounds
SG11201804814YA (en) Materials and methods for delivering nucleic acids to cochlear and vestibular cells
SG11201908919XA (en) Combination therapies targeting pd-1, tim-3, and lag-3
SG11201903697WA (en) Liver organoid compositions and methods of making and using same
SG11201901206SA (en) Trimer stabilizing hiv envelope protein mutations
SG11201804070XA (en) Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a
SG11201805570WA (en) Systems and methods for long term transdermal administration
SG11201804384UA (en) Geometric configurations for gastric residence systems
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201805680SA (en) Methods and compositions for the treatment of neurologic disease
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201807041PA (en) Improved preparations of adult liver progenitor cells
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201810965YA (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
SG11201809534UA (en) Methods of treating autoimmune disease using allogeneic t cells
SG11201808592PA (en) Method for selection of high m6p recombinant proteins
SG11201903061YA (en) Combination treatments comprising administration of imidazopyrazinones